Global ConSeptS – Consultancy is an independent technical consultancy company that was established in 2008. The company specialises in aseptic processing and Quality by Design projects specific to the global bio-pharmaceutical industry. Our approach is pragmatic and to-the-point. You are our customer and we want you to get the best technical solution rather than a theoretical proposal. Although today Global ConSeptS is a one-man company, we want you to be best served. That is why we closely work together with other competent consultancy companies to provide you the best quality for your projects and assure you on-time delivery.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…
We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…
Advertising, Branding, Clinical Research, Conference/meetings/events, Creative and design, Digital communications, Management consultancies, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Public relations, Regulatory affairs
Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…
Company Details
Latest Content from PMHub
White Papers and Resources | March 21, 2023 | Inizio
Watch part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years.
Press Releases | March 20, 2023 | Springer Nature
Catching the attention of time-strapped healthcare professionals is hard, but not impossible.
White Papers and Resources | March 16, 2023 | Avalere Health
Our policy and market access experts at Avalere, part of Fishawack Health, share insights on the reimbursement challenges for cell and gene therapies and discuss the challenges and opportunities of...
White Papers and Resources | March 16, 2023 | Avalere Health
Digital therapeutics can increase the value of medicinal assets, driving differentiation and improving outcomes for patients. But are manufacturers prepared to capitalize on this significant untapped opportunity before the tech...
Videos and Podcasts | March 16, 2023 | Impetus Digital
In this episode of Impetus Digital's Fireside Chat, Natalie Yeadon, Co-Founder and CEO of Impetus Digital sits down with Mike Waldron, who is the CEO and Co-Founder of Propel VR....
Press Releases | March 16, 2023 | Medscape Education
Women's health is a topic of increasing importance and interest among the medical community. Beyond impacting the individual patient, women's health is a public health issue in communities around the...
Press Releases | March 13, 2023 | Medscape Education
As cardiologists from around the world return home from New Orleans and ACC 2023, Medscape Education is looking back at a successful conference.At this year’s event, the Medscape Education team...
White Papers and Resources | March 13, 2023 | Impetus Digital
In recent years, social media has evolved into an essential part of Pharma operations, for better or worse.
White Papers and Resources | March 13, 2023 | The Creative Engagement Group
Our Insights Report is available now! We asked change and communications professionals and behavioural scientists from around the world to share insights and experiences to explore how, together, we can change...
Videos and Podcasts | March 13, 2023 | Medscape Education
Rare Disease Day may be over but our committment to advancing outcomes for patients continues. Watch this video to understand a patient's journey with pustular psoriasis.To learn more about Medscape's rare...